197 related articles for article (PubMed ID: 22221582)
1. Cytosolic, but not mitochondrial, oxidative stress is a likely contributor to cardiac hypertrophy resulting from cardiac specific GLUT4 deletion in mice.
Li Y; Wende AR; Nunthakungwan O; Huang Y; Hu E; Jin H; Boudina S; Abel ED; Jalili T
FEBS J; 2012 Feb; 279(4):599-611. PubMed ID: 22221582
[TBL] [Abstract][Full Text] [Related]
2. The antioxidant tempol inhibits cardiac hypertrophy in the insulin-resistant GLUT4-deficient mouse in vivo.
Ritchie RH; Quinn JM; Cao AH; Drummond GR; Kaye DM; Favaloro JM; Proietto J; Delbridge LM
J Mol Cell Cardiol; 2007 Jun; 42(6):1119-28. PubMed ID: 17490678
[TBL] [Abstract][Full Text] [Related]
3. Glucose transporter 4-deficient hearts develop maladaptive hypertrophy in response to physiological or pathological stresses.
Wende AR; Kim J; Holland WL; Wayment BE; O'Neill BT; Tuinei J; Brahma MK; Pepin ME; McCrory MA; Luptak I; Halade GV; Litwin SE; Abel ED
Am J Physiol Heart Circ Physiol; 2017 Dec; 313(6):H1098-H1108. PubMed ID: 28822962
[TBL] [Abstract][Full Text] [Related]
4. Hsp22 overexpression induces myocardial hypertrophy, senescence and reduced life span through enhanced oxidative stress.
Morin D; Long R; Panel M; Laure L; Taranu A; Gueguen C; Pons S; Leoni V; Caccia C; Vatner SF; Vatner DE; Qiu H; Depre C; Berdeaux A; Ghaleh B
Free Radic Biol Med; 2019 Jun; 137():194-200. PubMed ID: 31047988
[TBL] [Abstract][Full Text] [Related]
5. Glutathione redox state regulates mitochondrial reactive oxygen production.
Shen D; Dalton TP; Nebert DW; Shertzer HG
J Biol Chem; 2005 Jul; 280(27):25305-12. PubMed ID: 15883162
[TBL] [Abstract][Full Text] [Related]
6. Macrophage migration inhibitory factor antagonizes pressure overload-induced cardiac hypertrophy.
Koga K; Kenessey A; Ojamaa K
Am J Physiol Heart Circ Physiol; 2013 Jan; 304(2):H282-93. PubMed ID: 23144312
[TBL] [Abstract][Full Text] [Related]
7. Puerarin-7-O-glucuronide, a water-soluble puerarin metabolite, prevents angiotensin II-induced cardiomyocyte hypertrophy by reducing oxidative stress.
Hou N; Cai B; Ou CW; Zhang ZH; Liu XW; Yuan M; Zhao GJ; Liu SM; Xiong LG; Luo JD; Luo CF; Chen MS
Naunyn Schmiedebergs Arch Pharmacol; 2017 May; 390(5):535-545. PubMed ID: 28210753
[TBL] [Abstract][Full Text] [Related]
8. The antioxidant tempol attenuates pressure overload-induced cardiac hypertrophy and contractile dysfunction in mice fed a high-fructose diet.
Chess DJ; Xu W; Khairallah R; O'Shea KM; Kop WJ; Azimzadeh AM; Stanley WC
Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2223-30. PubMed ID: 18931030
[TBL] [Abstract][Full Text] [Related]
9. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.
Li HL; Wang AB; Huang Y; Liu DP; Wei C; Williams GM; Zhang CN; Liu G; Liu YQ; Hao DL; Hui RT; Lin M; Liang CC
Free Radic Biol Med; 2005 Jan; 38(2):243-57. PubMed ID: 15607907
[TBL] [Abstract][Full Text] [Related]
10. Calorie restriction attenuates hypertrophy-induced redox imbalance and mitochondrial ATP-sensitive K
David CEB; Lucas AMB; Araújo MTS; Coelho BN; Neto JBS; Portela BRC; Varela ALN; Kowaltowski AJ; Facundo HT
J Nutr Biochem; 2018 Dec; 62():87-94. PubMed ID: 30286377
[TBL] [Abstract][Full Text] [Related]
11. Antioxidative Effects of Tempol on Mitochondrial Dysfunction in Diabetic Nephropathy.
Ranjbar A; Kheiripour N; Ghasemi H; Seif Rabiei MA; Dadras F; Khoshjou F
Iran J Kidney Dis; 2018 Mar; 12(2):84-90. PubMed ID: 29507270
[TBL] [Abstract][Full Text] [Related]
12. Insulin-induced recurrent hypoglycemia exacerbates diabetic brain mitochondrial dysfunction and oxidative imbalance.
Cardoso S; Santos RX; Correia SC; Carvalho C; Santos MS; Baldeiras I; Oliveira CR; Moreira PI
Neurobiol Dis; 2013 Jan; 49():1-12. PubMed ID: 22940631
[TBL] [Abstract][Full Text] [Related]
13. Combination of angiotensin II and l-NG-nitroarginine methyl ester exacerbates mitochondrial dysfunction and oxidative stress to cause heart failure.
Hamilton DJ; Zhang A; Li S; Cao TN; Smith JA; Vedula I; Cordero-Reyes AM; Youker KA; Torre-Amione G; Gupte AA
Am J Physiol Heart Circ Physiol; 2016 Mar; 310(6):H667-80. PubMed ID: 26747502
[TBL] [Abstract][Full Text] [Related]
14. The role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase.
Li S; Yan T; Yang JQ; Oberley TD; Oberley LW
Cancer Res; 2000 Jul; 60(14):3927-39. PubMed ID: 10919671
[TBL] [Abstract][Full Text] [Related]
15. Effects of the antioxidant drug tempol on renal oxygenation in mice with reduced renal mass.
Lai EY; Luo Z; Onozato ML; Rudolph EH; Solis G; Jose PA; Wellstein A; Aslam S; Quinn MT; Griendling K; Le T; Li P; Palm F; Welch WJ; Wilcox CS
Am J Physiol Renal Physiol; 2012 Jul; 303(1):F64-74. PubMed ID: 22492941
[TBL] [Abstract][Full Text] [Related]
16. Melatonin alleviates angiotensin-II-induced cardiac hypertrophy via activating MICU1 pathway.
Yang Y; Du J; Xu R; Shen Y; Yang D; Li D; Hu H; Pei H; Yang Y
Aging (Albany NY); 2020 Nov; 13(1):493-515. PubMed ID: 33259334
[TBL] [Abstract][Full Text] [Related]
17. Glutathione and antioxidant enzymes serve complementary roles in protecting activated hepatic stellate cells against hydrogen peroxide-induced cell death.
Dunning S; Ur Rehman A; Tiebosch MH; Hannivoort RA; Haijer FW; Woudenberg J; van den Heuvel FA; Buist-Homan M; Faber KN; Moshage H
Biochim Biophys Acta; 2013 Dec; 1832(12):2027-34. PubMed ID: 23871839
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of lipid infusion-induced skeletal muscle insulin resistance by cotreatment with tempol and glutathione in mice.
Kim BS; Cha HN; Kim YW; Kim JY; Dan JM; Park SY
J Pharmacol Sci; 2009 Jul; 110(3):370-80. PubMed ID: 19609068
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of antioxidant Tempol on cardiac stem cells in chronic pressure overload hypertrophy.
Saheera S; Potnuri AG; Nair RR
Life Sci; 2019 Apr; 222():88-93. PubMed ID: 30822425
[TBL] [Abstract][Full Text] [Related]
20. Protection of myocytes against free radical-induced damage by accelerated turnover of the glutathione redox cycle.
Le CT; Hollaar L; Van der Valk EJ; Franken NA; Van Ravels FJ; Wondergem J; Van der Laarse A
Eur Heart J; 1995 Apr; 16(4):553-62. PubMed ID: 7671903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
